您的位置: 首页 > 农业专利 > 详情页

Heterocyclic ITK inhibitors for treating inflammation and cancer
专利权人:
ACLARIS THERAPEUTICS; INC.
发明人:
Eric Jon Jacobsen,James Robert Blinn,John Robert Springer,Susan L. Hockerman
申请号:
US15609876
公开号:
US10150783B2
申请日:
2017.05.31
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Disclosed herein are heterocyclic compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structure of Formula (I):wherein R1, R2, and X are as defined in the detailed description. Methods of inhibition of ITK activity in a human or animal subject are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充